Crizanlizumab: A CRITICAL Drug During a CRITICAL Time?

[Figure: see text]

Detalles Bibliográficos
Autores principales: Gue, Ying X., Pula, Giordano, Lip, Gregory Y.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733743/
https://www.ncbi.nlm.nih.gov/pubmed/35024499
http://dx.doi.org/10.1016/j.jacbts.2021.10.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733743/
https://www.ncbi.nlm.nih.gov/pubmed/35024499
http://dx.doi.org/10.1016/j.jacbts.2021.10.013

Ejemplares similares